Researchers develop personalized stem cell model ALS for fast, individualized drug testing
Amyotrophic lateral sclerosis (ALS) is a fast-progressing neurodegenerative disease with an average survival time of three years. In ALS, certain types of neurons called motor neurons that are required for muscle contractions die off, leading to progressive paralysis affecting most muscles of the body. The molecular causes of ALS are poorly understood, and effective treatments are missing.
To study ALS in the lab, Hideyuki Okano and his colleagues from Keio University, Japan, developed a new method to make motor neurons from stem cells taken directly from ALS patients. The results were published today in the journal Stem Cell Reports. ...












